z-logo
open-access-imgOpen Access
TBIO-11. The glutamine transporter and candidate diagnostic and therapeutic target SLC1A5 is associated with subtype-specific metabolic phenotypes and tumor prognosis in pediatric brain cancers
Author(s) -
Adam Kraya,
Run Jin,
Chao Zhao,
Ariana Familiar,
Kathryn E. Wellen,
Adam Resnick,
Ali Nabavizadeh
Publication year - 2022
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noac079.693
Subject(s) - glutamine , amino acid transporter , transporter , brain tumor , biology , cancer research , phenotype , ependymoma , solute carrier family , glioma , transcriptome , amino acid , medicine , pathology , gene expression , gene , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom